Philip J. Schneider is founder and principal of MediHealthInsight, which provides consultation to the industry and others on matters related to improving the use of medicines including the application of new technologies in healthcare.

He is also Chair, Alliance for Safe Biologic Medicines, International Advisory Board, which serves as an authoritative resource center of information for the public, as well as the healthcare and health policy communities, on the issues surrounding biologic medications.

Professor Schneider holds a faculty appointment as Professor at The Ohio State University College of Pharmacy.